Researchers successfully combine antibody-drug conjugate with immunotherapy to attack

[News]

To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years. Researchers from the University and University Hospital Basel have now for the first time successfully combined such an antibody-drug conjugate with a therapy that stimulates the immune system to attack tumor cells.

More... (http://www.news-medical.net/news/20151126/Researchers-successfully-combine-antibody-drug-conjugate-with-immunotherapy-to-attack-breast-cancer-cells.aspx)